Shandong Sanyuan Financials
| 301206 Stock | 25.58 0.17 0.67% |
Operating Margin | PE Ratio 53.2917 | Profit Margin | Payout Ratio 0.0178 | EPS Estimate Current Year 0.62 |
Shandong | Select Account or Indicator |
Understanding current and past Shandong Sanyuan Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Shandong Sanyuan's financial statements are interrelated, with each one affecting the others. For example, an increase in Shandong Sanyuan's assets may result in an increase in income on the income statement.
Please note, the presentation of Shandong Sanyuan's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Shandong Sanyuan's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Shandong Sanyuan's management manipulating its earnings.
Shandong Sanyuan Stock Summary
Shandong Sanyuan competes with Meinian Onehealth, Anhui Transport, Lander Sports, Everjoy Health, and Mingchen Health. Shandong Sanyuan is entity of China. It is traded as Stock on SHE exchange.Specialization | Consumer Defensive, Food, Beverage & Tobacco |
| Instrument | China Stock View All |
| Exchange | Shenzhen Stock Exchange |
| ISIN | CNE100005774 |
| Business Address | No 89, Zhangfu |
| Sector | Food Products |
| Industry | Consumer Staples |
| Benchmark | Dow Jones Industrial |
| Website | www.sanyuanbz.com |
| Phone | 86 54 3352 9851 |
You should never invest in Shandong Sanyuan without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Shandong Stock, because this is throwing your money away. Analyzing the key information contained in Shandong Sanyuan's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Shandong Sanyuan Key Financial Ratios
Shandong Sanyuan's financial ratios allow both analysts and investors to convert raw data from Shandong Sanyuan's financial statements into concise, actionable information that can be used to evaluate the performance of Shandong Sanyuan over time and compare it to other companies across industries.| Revenue | 499.5 M | ||||
| Gross Profit | 65.15 M | ||||
| EBITDA | 62.1 M | ||||
| Net Income | 58.87 M | ||||
| Total Asset | 4.81 B |
Shandong Sanyuan Key Balance Sheet Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Total Assets | 781.4M | 1.6B | 4.9B | 4.8B | 5.5B | 2.8B | |
| Other Current Liab | 148.6K | 226.4K | 168.1K | 2.3M | 2.1M | 1.0M | |
| Retained Earnings | 289.6M | 821.5M | 833.8M | 745.1M | 856.8M | 625.0M | |
| Accounts Payable | 238.8M | 542.5M | 184.3M | 208.6M | 239.9M | 293.1M | |
| Cash | 225.0M | 515.7M | 489.0M | 108.8M | 125.1M | 118.9M | |
| Net Receivables | 70.9M | 141.4M | 51.0M | 78.7M | 90.5M | 83.2M | |
| Inventory | 68.2M | 112.2M | 96.8M | 104.3M | 120.0M | 94.0M | |
| Other Current Assets | 5.5M | 6.1M | 23.2M | 10.1M | 11.6M | 9.9M | |
| Total Liab | 271.5M | 588.8M | 249.1M | 272.4M | 313.3M | 342.6M | |
| Net Invested Capital | 509.9M | 1.0B | 4.6B | 4.5B | 5.2B | 5.5B | |
| Total Current Assets | 378.7M | 805.6M | 669.4M | 321.8M | 370.1M | 531.2M | |
| Net Working Capital | 119.8M | 240.8M | 461.9M | 97.6M | 112.3M | 217.7M | |
| Intangible Assets | 30.1M | 49.1M | 48.7M | 47.6M | 54.7M | 45.4M |
Shandong Sanyuan Key Income Statement Accounts
An income statement is very similar to a cash flow statement, but instead of showing net revenue minus expenses, it only includes earnings before interest and taxes (EBIT). This number does not have all of the same line items that are on a cash flow statement, but it leaves out non-cash expenses like depreciation and amortization. For example, if you bought $100 worth of goods from Walmart (WMT) using your debit card that has an interest rate of 20%, then paid off the balance at the end of the month with a credit card that charges 30% interest, you would have an income statement showing EBIT of $80 because your expenses are lower than the amount that went into your pocket.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Tax Provision | 37.6M | 84.5M | 20.3M | 2.8M | 2.6M | 2.4M | |
| Net Interest Income | 1.7M | 2.8M | 13.6M | 5.2M | 5.9M | 5.6M | |
| Interest Income | 2.1M | 3.5M | 13.9M | 5.4M | 6.2M | 6.2M | |
| Selling General Administrative | 8.6M | 9.7M | 9.9M | 8.2M | 9.4M | 9.7M | |
| Total Revenue | 783.2M | 1.7B | 674.9M | 499.5M | 449.6M | 657.5M | |
| Gross Profit | 331.0M | 703.5M | 94.9M | 15.2M | 13.7M | 13.0M | |
| Operating Income | 282.6M | 625.2M | 48.4M | (58.0M) | (52.2M) | (49.6M) | |
| Net Income From Continuing Ops | 232.6M | 535.4M | 163.7M | 58.9M | 53.0M | 50.3M | |
| Research Development | 30.3M | 59.0M | 34.1M | 50.7M | 58.3M | 42.6M | |
| Cost Of Revenue | 452.1M | 971.8M | 580.0M | 484.3M | 556.9M | 604.3M | |
| Total Operating Expenses | 500.5M | 1.1B | 626.5M | 557.5M | 641.1M | 668.5M | |
| Reconciled Depreciation | 16.9M | 25.6M | 38.7M | 59.6M | 68.5M | 72.0M | |
| Income Before Tax | 270.1M | 619.9M | 184.0M | 61.7M | 55.5M | 52.8M | |
| Net Income | 232.6M | 535.4M | 163.7M | 58.9M | 53.0M | 50.3M |
Shandong Sanyuan Key Cash Accounts
Cash flow analysis captures how much money flows into and out of Shandong Sanyuan Bio. It measures of how well Shandong is doing because it can show the actual money that comes into and out of the Company from sales instead of measuring expenses against revenue to determine earnings. You have to read the cash flow statement in three sections. The first section shows how much money Shandong Sanyuan brought in, usually known as net revenue or sales. This is different from earnings because it does not include expenses when determining net revenue for use on this part of the cash flow statement. Next, are operating activities, which show how much money Shandong had leftover after paying for its expenses. This number can be calculated in two ways: by subtracting the total of all operating expenses from net revenue or by adding up changes to cash and other assets or liabilities on this part of the statement. The third section is about investing activities, which shows what Shandong Sanyuan has done with the money that it received from the sale of assets or what it spent to acquire new ones. This section can be broken down into two parts: investing in existing businesses (in other words, buying more stock) and investing in non-business activities like paying off debt or making acquisitions.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change To Inventory | (22.3M) | (44.0M) | 10.2M | (2.5M) | (2.9M) | (3.1M) | |
| Investments | (147.5M) | (445.9M) | (3.3B) | (280.1M) | (252.1M) | (264.7M) | |
| Change In Cash | (16.3M) | 200.2M | 210.6M | (364.5M) | (328.1M) | (311.7M) | |
| Free Cash Flow | 65.6M | 207.7M | (158.4M) | (65.7M) | (59.1M) | (56.2M) | |
| Change In Working Capital | (39.2M) | 79.1M | (37.2M) | 50.4M | 57.9M | 60.8M | |
| Begin Period Cash Flow | 74.1M | 57.8M | 257.9M | 468.5M | 538.8M | 565.7M | |
| Depreciation | 16.9M | 25.6M | 38.7M | 59.6M | 68.5M | 72.0M | |
| Dividends Paid | 70.8M | 943.06 | 134.9M | 143.2M | 164.6M | 172.9M | |
| Capital Expenditures | 151.8M | 434.4M | 242.7M | 123.0M | 141.4M | 240.4M | |
| Total Cash From Operating Activities | 217.4M | 642.1M | 84.3M | 57.3M | 51.6M | 49.0M | |
| Net Income | 232.6M | 535.4M | 163.7M | 58.9M | 53.0M | 50.3M | |
| End Period Cash Flow | 57.8M | 257.9M | 468.5M | 104.0M | 119.6M | 211.7M |
Shandong Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Shandong Sanyuan's current stock value. Our valuation model uses many indicators to compare Shandong Sanyuan value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Shandong Sanyuan competition to find correlations between indicators driving Shandong Sanyuan's intrinsic value. More Info.Shandong Sanyuan Biotechnology is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Shandong Sanyuan by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Shandong Sanyuan's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Shandong Sanyuan Bio Systematic Risk
Shandong Sanyuan's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Shandong Sanyuan volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Shandong Sanyuan Bio correlated with the market. If Beta is less than 0 Shandong Sanyuan generally moves in the opposite direction as compared to the market. If Shandong Sanyuan Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Shandong Sanyuan Bio is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Shandong Sanyuan is generally in the same direction as the market. If Beta > 1 Shandong Sanyuan moves generally in the same direction as, but more than the movement of the benchmark.
Shandong Sanyuan Biotechnology Total Assets Over Time
Shandong Sanyuan Thematic Clasifications
Shandong Sanyuan Biotechnology is part of Biotech investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Biotechnology and pharmaceuticals production and services. Companies specialized in biotechnology production and delivery of pharmaceuticals services
This theme covers Biotechnology and pharmaceuticals production and services. Companies specialized in biotechnology production and delivery of pharmaceuticals services. Get More Thematic Ideas
| Biotech | View |
Shandong Sanyuan January 19, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Shandong Sanyuan help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Shandong Sanyuan Biotechnology. We use our internally-developed statistical techniques to arrive at the intrinsic value of Shandong Sanyuan Biotechnology based on widely used predictive technical indicators. In general, we focus on analyzing Shandong Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Shandong Sanyuan's daily price indicators and compare them against related drivers.
| Information Ratio | (0.03) | |||
| Maximum Drawdown | 9.13 | |||
| Value At Risk | (3.23) | |||
| Potential Upside | 3.29 |
Complementary Tools for Shandong Stock analysis
When running Shandong Sanyuan's price analysis, check to measure Shandong Sanyuan's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Shandong Sanyuan is operating at the current time. Most of Shandong Sanyuan's value examination focuses on studying past and present price action to predict the probability of Shandong Sanyuan's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Shandong Sanyuan's price. Additionally, you may evaluate how the addition of Shandong Sanyuan to your portfolios can decrease your overall portfolio volatility.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |